EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudieKohortenstudieOpen Access · CC BY 4.0

Comparing the effectiveness of bivalent and monovalent COVID-19 vaccines against COVID-19 infection during the winter season of 2022-2023: A real-world retrospective observational matched cohort study in the Republic of Korea

Chungman Chae, Ryu Kyung Kim, Eun Jung Jang, Ji Ae Shim, Eunkyung Park, Kil Hun Lee, Sye Lim Hong, Asma Binte Aziz, Birkneh Tilahun Tadesse, Florian Marks, Sangwoo Tak, Sangwon Lee und 1 weitere

International Journal of Infectious Diseases · 2023

DOI: 10.1016/j.ijid.2023.08.010 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Infectious Diseases, 2023. Verfasst von Chungman Chae und 12 weiteren Autor:innen. Beteiligte Einrichtung: Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea. Electronic address: chungmanchae@gmail.com. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Vaccines, Vaccine Efficacy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To compare the effectiveness of bivalent and monovalent COVID-19 vaccines throughout the 2022-2023 winter season based on real-world data. METHODS: This retrospective observational matched cohort study used the national vaccination program and a surveillance dataset from the Republic of Korea, and included adults aged >18 years who received bivalent or monovalent COVID-19 vaccines between October 11, 2022, and December 17, 2022. Cox proportional hazard models were used to estimate the hazard ratio for COVID-19 infection between the groups. RESULTS: We included 29,245 matched individuals in the bivalent and monovalent vaccine groups, respectively. The bivalent vaccine recipients showed 12.2% (95% confidence interval [CI] 6.5-17.7%) additional protection against COVID-19 infection compared with the monovalent vaccine recipients. The additional protection provided by bivalent vaccines was significantly higher among residents of long-term care facilities (39.4%, 95% CI 21.6-53.1%). Maximum additional protection was observed 3 to 4 months after completing the vaccination (17.6%, 95% CI 6.6-27.3%). CONCLUSION: Bivalent COVID-19 vaccines showed significantly better protection against infection than monovalent vaccines among adults during the 2022-2023 winter season. Our results highlight that immunization programs with bivalent vaccines comprising recent variants can be an effective measure to prepare for seasonal COVID-19 circulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2COVID-19 VaccinesVaccine EfficacyHumansRepublic of KoreaRetrospective StudiesFemaleMaleMiddle AgedSeasonsAdultAgedVaccination

Stichwörter der Autor:innen

BivalentCOVID-19InfectionMonovalentRetrospectiveVaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea. Electronic address: chungmanchae@gmail.com.
  • Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
  • International Vaccine Institute, Seoul, Republic of Korea.
  • International Vaccine Institute, Seoul, Republic of Korea; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridg…

Zitieren

APA

Chae, C., Kim, R. K., Jang, E. J., Shim, J. A., Park, E., Lee, K. H., Hong, S. L., Aziz, A. B., Tadesse, B. T., Marks, F., Tak, S., Lee, S., & Kwon, D. (2023). Comparing the effectiveness of bivalent and monovalent COVID-19 vaccines against COVID-19 infection during the winter season of 2022-2023: A real-world retrospective observational matched cohort study in the Republic of Korea. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2023.08.010

Vancouver

Chae C, Kim RK, Jang EJ, Shim JA, Park E, Lee KH, et al. Comparing the effectiveness of bivalent and monovalent COVID-19 vaccines against COVID-19 infection during the winter season of 2022-2023: A real-world retrospective observational matched cohort study in the Republic of Korea. International Journal of Infectious Diseases. 2023. doi:10.1016/j.ijid.2023.08.010

BibTeX
@article{Chae2023,
  author = {Chae, Chungman and Kim, Ryu Kyung and Jang, Eun Jung and Shim, Ji Ae and Park, Eunkyung and Lee, Kil Hun and Hong, Sye Lim and Aziz, Asma Binte and Tadesse, Birkneh Tilahun and Marks, Florian and Tak, Sangwoo and Lee, Sangwon and Kwon, Donghyok},
  title = {Comparing the effectiveness of bivalent and monovalent COVID-19 vaccines against COVID-19 infection during the winter season of 2022-2023: A real-world retrospective observational matched cohort study in the Republic of Korea},
  journal = {International Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1016/j.ijid.2023.08.010}
}
Kostenlos starten →